Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1

被引：6
|
作者：
Thomas, S. [1 ,2 ]
Laino, A. [1 ,2 ]
Sturm, R. [1 ]
Nufer, K. [1 ]
Lambie, D. [2 ,3 ]
Shepherd, B. [2 ]
Atkinson, V. [4 ]
Adams, L. [1 ]
Soyer, H. P. [1 ,2 ]
Schaider, H. [1 ]
机构：
[1] Univ Queensland, Translat Res Inst, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia
[2] Princess Alexandra Hosp, Dept Dermatol, Brisbane, Qld, Australia
[3] IQ Pathol, Brisbane, Qld, Australia
[4] Princess Alexandra Hosp, Dept Med Oncol, Brisbane, Qld, Australia
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2018年 / 32卷 / 05期
关键词：
MALIGNANT-MELANOMA; MANAGEMENT; COHORT;
D O I：
10.1111/jdv.14678
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E176 / E177
页数：2
相关论文
共 50 条
  • [31] Management of Localized Melanoma in the Anti-PD-1 Era
    Novis, Elan
    van Akkooi, Alexander C. J.
    CURRENT ONCOLOGY REPORTS, 2024, 26 (08) : 924 - 933
  • [32] Anti-PD-1 antibody treatment for melanoma Reply
    Beaver, Julia A.
    Keegan, Patricia
    Lemery, Steven
    Pazdur, Richard
    Theoret, Marc R.
    LANCET ONCOLOGY, 2018, 19 (05): : E220 - E220
  • [33] Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients
    Rossi, Ernesto
    Cellini, Francesco
    Pagliara, Monica Maria
    Sammarco, Maria Grazia
    Pedone, Romina Rose
    Lancellotta, Valentina
    Tagliaferri, Luca
    Quirino, Michela
    Gambacorta, Maria Antonietta
    Blasi, Maria Antonietta
    Tortora, Giampaolo
    Schinzari, Giovanni
    CANCERS, 2023, 15 (02)
  • [34] Anti-PD-1 immunotherapy in advanced metastatic melanoma: State of the art and future challenges
    Moreira, Rita S.
    Bicker, Joana
    Musicco, Felice
    Persichetti, Agnese
    Pereira, Andre M. P. T.
    LIFE SCIENCES, 2020, 240
  • [35] Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy
    Dupuis, Frantz
    Lamant, Laurence
    Gerard, Emilie
    Torossian, Nouritza
    Chaltiel, Leonor
    Filleron, Thomas
    Beylot-Barry, Marie
    Dutriaux, Caroline
    Prey, Sorilla
    Gros, Audrey
    Jullie, Marie-Laure
    Meyer, Nicolas
    Vergier, Beatrice
    BRITISH JOURNAL OF CANCER, 2018, 119 (02) : 193 - 199
  • [36] Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma
    Liniker, E.
    Menzies, A. M.
    Kong, B. Y.
    Cooper, A.
    Ramanujam, S.
    Lo, S.
    Kefford, R. F.
    Fogarty, G. B.
    Guminski, A.
    Wang, T. W.
    Carlino, M. S.
    Hong, A.
    Long, G. V.
    ONCOIMMUNOLOGY, 2016, 5 (09):
  • [37] Low-dose ipilimumab combined with anti-PD-1 immunotherapy in patients with metastatic melanoma following anti-PD-1 treatment failure
    Klee, Gina
    Kurzhals, Jonas
    Hagelstein, Victoria
    Zillikens, Detlef
    Recke, Andreas
    Langan, Ewan A.
    Terheyden, Patrick
    MELANOMA RESEARCH, 2021, 31 (05) : 464 - 471
  • [38] Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy
    de With, Mirjam
    Hurkmans, Daan P.
    Oomen-de Hoop, Esther
    Lalouti, Ayoub
    Bins, Sander
    El Bouazzaoui, Samira
    van Brakel, Mandy
    Debets, Reno
    Aerts, Joachim G. J. V.
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    van der Veldt, Astrid A. M.
    CANCERS, 2021, 13 (06) : 1 - 13
  • [39] Total RNA-transcriptomics for identification of predictors of overall survival in metastatic melanoma patients treated with anti-PD-1
    Xiao, Qingyang
    Oliver, Javier
    Luis Onieva, Juan
    Pineiro, Pilar
    Garrido-Aranda, Alicia
    Laborda-Illanes, Aurora
    Gallego, Elena
    Robles-Podadera, Cynthia
    Chica-Parrado, Rosario
    Prieto, Daniel
    Sanchez, Alfonso
    De Luque, Vanessa
    Jose Lozano, Maria
    Alvarez, Martina
    Jimenez, Pedro
    Alba, Emilio
    Berciano-Guerrero, Miguel
    Cobo, Manuel
    Barragan, Isabel
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [40] Prognostic models for advanced melanoma patients treated with anti-PD-1 monotherapy.
    Bai, Xue
    Kim, Michelle S.
    Kasumova, Gyulnara G.
    Cohen, Justine Vanessa
    Lawrence, Donald P.
    Freedman, Christine
    Fadden, Riley
    Rubin, Krista M.
    Sharova, Tatyana
    Flaherty, Keith
    Sullivan, Ryan J.
    Boland, Genevieve Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
12345